Skip to content
Global Life Sciences Update

HTA Regulation in the EU: A Blessing or a Burden for Market Access?

Share
Following the trialogue negotiations, on June 22, 2021, the Council of the European Union and the European Parliament reached a provisional agreement on the European Commission’s proposal for a European health technology assessment regulation (HTA Regulation), which aims to harmonize the clinical benefit assessment of health technologies across the EU. The scope of the proposal encompasses both medicinal products and medical devices, including in vitro diagnostics. The final agreed text is not available at the time of writing.

Attorney Advertising—Sidley Austin LLP is a global law firm. Our addresses and contact information can be found at www.sidley.com/en/locations/offices.

Sidley provides this information as a service to clients and other friends for educational purposes only. It should not be construed or relied on as legal advice or to create a lawyer-client relationship. Readers should not act upon this information without seeking advice from professional advisers. Sidley and Sidley Austin refer to Sidley Austin LLP and affiliated partnerships as explained at www.sidley.com/disclaimer.

© Sidley Austin LLP

Contacts

If you have any questions regarding this Sidley Update, please contact the Sidley lawyer with whom you usually work, or

Offices